Combined use of laser therapy and autologous plasma with cells in patients with post-acne atrophic scars

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background. Acne scar formation is a common consequence of acne vulgaris, in most cases atrophic scars resulting from tissue loss caused by inflammation of the pilosebial units.

Aims: To study the effectiveness of combined laser therapy with Nd:YAG laser and Er: YAG laser with autologous plasma with cells in patients with different phenotypes of post-acne atrophic scars.

Materials and methods. Depending on the method of treatment of post-acne scars, the patients were divided into 2 groups: Group 1 (n=28) with ice pick scars — 10 patients; boxcar — 9 patients; rolling — 9 patients and group 1 (n=30) among them with ice pick scars — 10; boxcar — 9; rolling — 11 patients. In group 1A, phototherapy was performed using a combination of Nd:YAG laser and Er:YAG laser. Immediately after laser exposure, autologous plasma was applied to the skin of the face of group 1B patients. To assess the effectiveness, the Manchester scale of assessment of scar deformities was used. The effectiveness was also evaluated using the Global Aesthetic Scale (GAIS) on a 3-point system. In this study, cutometry and ultrasound were performed to assess the elasticity of the skin in the foci of atrophy.

Results. The indicator "color" on the MSS scale improved in the 1st group by 54.8%, in the 2nd — by 83.7%, the indicator "texture" — by 57.1 and 78.1%, the indicator "relief" — by 43.8 and 66.7%, the indicator "displacement" — by 54.9 and 82.1%, respectively. There were no patients with a deterioration or lack of effect on the GAIS scale in any of the study groups. According to the ultrasound scan data, the greatest effectiveness was observed in the group of complex treatment .

Conclusion. Complex treatment, including the use of combined laser therapy (erbium and neodymium lasers) and autologous plasma with cells, is a highly effective technique for the treatment of atrophic post-acne scars.

全文:

受限制的访问

作者简介

Aliya Talibova

Central State Medical Academy of Department of Presidential Affairs

Email: tynrik@yandex.ru
ORCID iD: 0000-0003-0850-3238

Cand. Sci. (Med.)

俄罗斯联邦, Moscow

Natalia Gryazeva

Institute of Plastic Surgery and Cosmetology

编辑信件的主要联系方式.
Email: tynrik@yandex.ru
ORCID iD: 0000-0003-3437-5233
SPIN 代码: 1309-4668

Cand. Sci. (Med.)

俄罗斯联邦, Moscow

参考

  1. Acne and rosacea. Ed. by L.S. Kruglova Moscow: GEOTAR-Media; 2021. 207 р. (In Russ).
  2. Al Tawil AA, Al Refae AA, Hamed AM, Kamal AM. Comparative study of the effectiveness of platelet-rich plasma in combination with carboxytherapy compared to its use with a fractional carbon dioxide laser in atrophic acne scars. J Cosmeticol. 2018;18(1):150–155. doi: 10.1111/jocd.12561
  3. Al-Saedi SJ, Al-Hilo MM, Al-Shami S. Treatment of acne scars using fractional erbium:YAG-laser. Am J Dermatol Venereol. 2014;3(2):43–49. doi: 10.5923/j.ajdv.20140302.04
  4. Omi T, Numano K. The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther. 2014;23(1):49–60.
  5. doi: 10.5978/islsm.14-RE-01
  6. Potekaev NN, Kruglova LS. Laser in dermatology and cosmetology. Moscow: MDV; 2012. 280 р. (In Russ).
  7. Kumaran MS, Arshdeep A. Platelet-rich plasma in dermatology: a blessing or a curse? Indian J Dermatol Venereol Leprol. 2014;80(1):5–14. doi: 10.4103/0378-6323.125467
  8. Abdel-Aal AM, Ibrahim IM, Sami NA, Abdel Karim IM. Evaluation of autologous platelet-rich plasma plus ablative fractional carbon dioxide laser in the treatment of acne scars. J Cosmetic Laser Ther. 2018;20(2):106–113. doi: 10.1080/14764172.2017.1368667

补充文件

附件文件
动作
1. JATS XML
2. Figure. Comparative data of cutometry (p <0.01, comparison with the indicator before therapy) in patients with post-acne scars (Ua / Uf),%.

下载 (52KB)

版权所有 © Eco-Vector, 2020



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86508 от 11.12.2023
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80650 от 15.03.2021
г.